[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"home-based-rehabilitation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:home-based-rehabilitation":117},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,43,59,89],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100580440","effect-of-untact-upper-extremity-rehabilitation-using-smart-glove-for-late-subacute-and-chronic-patients-with-brain-disorder-100580440",false,"NCT06837324","Effect of Untact Upper Extremity Rehabilitation Using Smart Glove for Late Subacute and Chronic Patients With Brain Disorder","A Multicenter Confirmation Clinical Trial of Untact Upper Extremity Rehabilitation Using Smart Glove for Late Subacute and Chronic Patients With Brain Disorder - a Randomized Single-blinded Controlled Trial","brain disorder","Inclusion Criteria:\n\n* Patients with brain disorder aged 19 to 85 years old\n* patients with hemiparesis lasting for more than 3 months due to neurological diseases (stroke, traumatic brain injury, brain tumor) and impaired upper limb function\n* Patients with spasticity of the wrist and finger flexors and extensors on the affected side, with a Modified Ashworth Scale (MAS) score of 1+ or lower\n* Participants with sufficient cognitive function to understand the instructions from the researcher and the smart glove, and to perform the tasks (K-MMSE ≥21)\n\nExclusion Criteria:\n\n* pre-existing significant neurogenic disorders\n* major psychiatric disorders such as schizophrenia, bipolar disorder, or dementia\n* History of diseases that caused pain or muscle atrophy in the affected upper limb before the onset of the neurological disease, which interfered with rehabilitation\n* Severe spasticity of the affected upper limb (Modified Ashworth Scale score ≥3)\n* skin disorders or open wounds on the affected upper limb\n* Amputation, fractures, or soft tissue-related diseases or injuries on the affected upper limb\n* severe pain that interferes with rehabilitation of the affected upper limb (Numeric Rating Scale \\> 6)\n* Inability to maintain a seated posture for more than 10 minutes\n* Significant visual impairment to the extent that the screen cannot be recognized when using the smart glove","ALL","19 Years","85 Years",{"count":21,"type":22},40,"ESTIMATED","INTERVENTIONAL",[25],"NA","The aim is to clinically validate the clinical efficacy, usability, and safety of home-based upper limb rehabilitation training using the Neofect Smart Glove by comparing the effects between a group using the home-based Neofect Smart Glove and a group performing conventional home-based occupational therapy in patients with upper limb dysfunction in the late subacute and chronic stages of neurological diseases.",[28,29],"Brain Disorder","Home Based Rehabilitation","RECRUITING","2026-04-23",{"date":33,"type":34},"2026-04-24","ACTUAL",{"date":36,"type":34},"2025-04-11",{"date":38,"type":22},"2026-12-31",{"name":40,"class":41},"Samsung Medical Center","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":50,"targetDuration":4,"studyType":23,"phases":51,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":54,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":58,"locationsCount":42},"100580443","effect-of-untact-upper-extremity-rehabilitation-using-a-smart-board-for-late-subacute-and-chronic-patients-with-brain-disorder-100580443","NCT06837363","Effect of Untact Upper Extremity Rehabilitation Using a Smart Board for Late Subacute and Chronic Patients With Brain Disorder","A Multicenter Confirmation Clinical Trial of Untact Upper Extremity Rehabilitation Using Smart Board for Late Subacute and Chronic Patients With Brain Disorder - a Randomized Single-blinded Controlled Trial","Inclusion Criteria:\n\n* Patients with neurological diseases aged 19 to 85 years old\n* Patients with hemiparesis lasting for more than 3 months due to neurological diseases (stroke, traumatic brain injury, brain tumor) and impaired upper limb function\n* Patients with shoulder flexor and adductor muscle strength of MRC grade 2 or higher\n* Patients with shoulder extensor and abductor spasticity of MAS grade 1+ or lower\n* Participants with sufficient cognitive function to understand the instructions from the researcher and the smart board, and to perform the tasks (K-MMSE ≥21)\n\nExclusion Criteria:\n\n* pre-existing significant neurogenic disorders\n* major psychiatric disorders such as schizophrenia, bipolar disorder, or dementia\n* History of diseases that caused pain or muscle atrophy in the affected upper limb before the onset of the neurological disease, which interfered with rehabilitation\n* Severe spasticity of the affected upper limb (Modified Ashworth Scale score ≥3)\n* skin disorders or open wounds on the affected upper limb\n* Amputation, fractures, or soft tissue-related diseases or injuries on the affected upper limb\n* severe pain that interferes with rehabilitation of the affected upper limb (Numeric Rating Scale \\> 6)\n* Inability to maintain a seated posture for more than 10 minutes, which is required for using the smart board\n* Significant visual impairment to the extent that the screen cannot be recognized when using the smart board",{"count":21,"type":22},[25],"The aim is to clinically validate the clinical efficacy, usability, and safety of home-based upper limb rehabilitation training using the Neofect Smart Board by comparing the effects between a group using the home-based Neofect Smart Board and a group performing conventional home-based occupational therapy in patients with upper limb dysfunction in the late subacute and chronic stages of neurological diseases.",[29,28],{"date":33,"type":34},{"date":56,"type":34},"2025-04-01",{"date":38,"type":22},{"name":40,"class":41},{"id":60,"slug":61,"hasResults":11,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":11,"sex":17,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":4,"studyType":23,"phases":71,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":42},"100631907","home-based-exercise-after-cervical-epidural-steroid-injection-for-cervical-radiculopathy-100631907","NCT07506785","Home-Based Exercise After Cervical Epidural Steroid Injection for Cervical Radiculopathy","Effect of a Home-Based Exercise Program After Cervical Interlaminar Epidural Steroid Injection on Clinical Outcomes in Patients With Chronic Cervical Radiculopathy: A Randomized Controlled Trial","CESI-HEP","Inclusion Criteria:\n\n* Age between 18 and 70 years.\n* Chronic cervical radicular pain lasting ≥3 months, characterized by neck pain with accompanying arm pain consistent with a cervical nerve root distribution.\n* Average pain intensity ≥4\u002F10 on the Numeric Rating Scale (NRS) over the preceding 7 days at baseline.\n* Diagnosis of chronic cervical radiculopathy due to cervical disc herniation, confirmed by clinical examination and cervical MRI findings at the corresponding level.\n* Insufficient response to conservative treatment, including physical therapy, medication, and\u002For exercise therapy.\n* Ability to provide written informed consent and comply with study procedures.\n\nExclusion Criteria:\n\n* Patients were excluded if any of the following were present:\n* Clinical signs of cervical myelopathy or progressive neurological deficit.\n* Suspicion of serious spinal pathology (e.g., infection, malignancy).\n* Contraindications to epidural steroid injection, including uncontrolled coagulopathy, anticoagulant therapy not appropriately managed, or local\u002Fsystemic infection.\n* Pregnancy.\n* Prior cervical spine surgery or cervical epidural steroid injection within the prespecified washout period.\n* Severe musculoskeletal or neurological comorbidities that could interfere with safe participation in the exercise program.\n* Discordance between clinical symptoms and imaging findings.","18 Years","70 Years",{"count":70,"type":22},60,[25],"Cervical radiculopathy is a common cause of neck and arm pain resulting from compression or inflammation of a cervical nerve root. Cervical epidural steroid injection is frequently used to reduce pain and improve function in patients who do not respond to conservative treatment. However, long-term functional recovery may require additional rehabilitation strategies. This randomized controlled trial aims to investigate whether adding a standardized home-based exercise program after cervical interlaminar epidural steroid injection improves pain, disability, sleep quality, and quality of life in patients with chronic cervical radiculopathy. Participants will be randomly assigned to receive either injection alone or injection followed by an eight-week home-based exercise program.",[74,29],"Cervical Radiculopathy",[76,77,78,79],"Cervical Epidural Steroid Injection","Neck Pain","cervical radiculopathy","Home based exercise","2026-03-28",{"date":82,"type":34},"2026-04-02",{"date":84,"type":34},"2026-02-01",{"date":86,"type":22},"2026-06",{"name":88,"class":41},"Necmettin Erbakan University",{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":93,"acronym":94,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":17,"minAge":67,"maxAge":96,"enrollmentInfo":97,"targetDuration":4,"studyType":23,"phases":99,"briefSummary":100,"conditions":101,"keywords":103,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":116},"100564153","development-and-implementation-model-of-home-based-cardiac-rehabilitation-with-family-empowerment-approach-in-patient-with-acs-hbcr-in-acs-100564153","NCT06625463","Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS)","HBCR in ACS","Inclusion Criteria:\n\n1. Patients with acute coronary syndrome who have undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of interview.\n2. Aged 18-65 years, participants were selected with age variations representing young adults, adults and the elderly.\n3. Patients with first experience of SCA, participants were selected whether they had undergone PCI or not.\n4. Patients living with family and family involved in the patient care process.\n5. Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP\n\n   \\>90, systolic \\<150 mmhg; N: 60-100x\u002Fmin; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument.\n6. Willing to participate in the study.\n\nExclusion Criteria:\n\n* Patients with comorbidities that require routine medication such as Diabetes Mellitus, hypertension, renal failure","65 Years",{"count":98,"type":22},90,[25],"The aim of this clinical trial is to determine whether home-based cardiac rehabilitation with a family empowerment approach can help acute coronary syndrome patients recover. The main questions to be answered are:\n\n\\- Does home-based cardiac rehabilitation with a family approach effective in patients with acute coronary syndrome to improve health-related quality of life and peak Vo2? Researchers will compare with usual care to see if home-based cardiac rehabilitation with a family approach is more effective for improving health-related quality of life and peak Vo2 in ACS patients.\n\nPatient inclusion criteria\n\n1. Patients with acute coronary syndrome who had undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of the interview.\n2. Aged 18-65 years old, participants were selected with age variations representing young adults, adults and the elderly.\n3. Patients with first experience of SCA, participants were selected whether they had undergone PCI or not.\n4. Patients living with family and family involved in the patient care process.\n5. Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP\n\n   \\>90, systolic \\<150 mmhg; N: 60-100x\u002Fmin; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument.\n6. Willing to participate in the study.\n\nParticipants will:\n\nFor 12 weeks\n\n1. Perform walking exercises as prescribed\n2. Implement diets and stress management according to the module\n3. Quit smoking\n4. Medication compliance\n5. visit the clinic to see a cardiologist, undergo a 6-minute walk test",[29,102],"Acute Coronary Syndromes",[104,105,106],"home based cardiac rehabilitation","FCEM","acute coronary syndromes","2025-06-11",{"date":109,"type":34},"2025-06-15",{"date":111,"type":34},"2025-01-01",{"date":113,"type":22},"2025-09-30",{"name":115,"class":41},"Gadjah Mada University",2,"Home-based Rehabilitation"]